Medical
Pharmaceutical
Research And Development

Madrigal Pharmaceuticals

279

$64.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.30 (+2.07%) As of 10:35 AM EDT today
+$1.30 (+2.07%) Today

Why Robinhood?

You can buy or sell MDGL and other stocks, options, ETFs, and crypto commission-free!

About MDGL

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Read More The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

CEO
Paul A. Friedman
Employees
29
Headquarters
West Conshohocken, Pennsylvania
Founded
2011
Market Cap
1.02B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
264.76K
High Today
$64.46
Low Today
$63.29
Open Price
$63.77
Volume
39.51K
52 Week High
$145.16
52 Week Low
$56.82

Collections

Medical
Pharmaceutical
Research And Development
Health
Cancer Prevention
Technology

MDGL Earnings

-$1.80
-$1.20
-$0.60
-$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, Pre-Market

People Also Bought

Viking Therapeutics

52,999

$4.67

+2.19%

Viking Therapeutics

52,999

$4.67

+2.19%

Sangamo Therapeutics

7,470

$6.79

0.00%

Amarin

34,293

$5.33

+5.65%

Nektar Therapeutics

4,573

$17.71

+0.65%

You May Also Like

KURE
ESE
NWPX
ESGS
PSMMY
OPTT
ALL
VIOT
LOOP
WARFY
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MDGL

Market Price$64.12
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MDGL stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up